Rose C. Perri is Director at GENEREX BIOTECHNOLOGY CORP (GNBT). They have made 6 open-market trades across 1 company since 2008, most recently 2011-05-09.
CIK 0001125858
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $29K since 2008, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GNBT | 975,478 | — |
Shares reported on the most recent Form 4, priced at the 2011-05-11 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GNBT | SELL | 2011-05-09 | 2011-05-11 | $0.23 | $3K | N/A | N/A | N/A |
| GNBT | SELL | 2011-05-06 | 2011-05-09 | $0.23 | $5K | N/A | N/A | N/A |
| GNBT | SELL | 2011-05-03 | 2011-05-04 | $0.22 | $6K | N/A | N/A | N/A |
| GNBT | BUY | 2010-10-27 | 2010-10-27 | $0.35 | $19K | N/A | N/A | N/A |
| GNBT | BUY | 2009-11-16 | 2009-11-16 | $0.51 | $5K | N/A | N/A | N/A |
| GNBT | BUY | 2008-10-13 | 2008-10-14 | $0.30 | $5K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.